Refractec says the FDA has approved its equipment, which is used for a new form of corrective eye surgery. The procedure, known as "conductive keratoplasty," or CK, is similar to LASIK surgery, but uses radiofrequency waves instead of a laser to reshape the cornea, which Refractec says is less invasive and causes less side effects.

Full Story:

Related Summaries